Cosmetic Compliance
Intelligence & Solutions
Home / News / Details

Japan Issued Instructions for Advertising Quasi-drugs with Wrinkle Improvement Claims

Age-related wrinkle improvements claims are acceptable for quasi-drugs. However, age-related wrinkle improvement claims associated with youthfulness are prohibited.

On August 30, 2024, the Japan Cosmetic Industry Association (JCIA) issued a new instruction regarding the advertising of quasi-drugs that have wrinkle improvement claims. The instruction emphasizes the importance of accurately representing approved effects and provides five key points for compliance.

Please Log in or Sign up (FREE) to read the full content.
We provide full-scale global cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by cosmetic@chemlinked.com
Copyright: unless otherwise stated all contents of this website are ©2024 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact cleditor@chemlinked.com
User Guide